FDA Warning Letter — Surgisil, LLP
The FDA took a Warning Letter action against Surgisil, LLP on April 15, 2019 (Plano, TX). The action was issued by CDRH and concerns devices products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Surgisil, LLP
- Date
- April 15, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Center
- CDRH
- Location
- Plano, TX (United States)